F L Graham - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

F L Graham

Showing results (151-160 of 186) with videos related to

Pageof 19

Sort By:

The Journal of General Virology|October 1, 1993

Mouse hepatitis virus spike and nucleocapsid proteins expressed by adenovirus vectors protect mice against a lethal infectionJ G Wesseling, G J Godeke, V E Schijns, et al.

Journal of Immunology (Baltimore, Md. : 1950)|January 23, 1999

A single intramuscular injection with an adenovirus-expressing IL-12 protects BALB/c mice against Leishmania major infection, while treatment with an IL-4-expressing vector increases disease susceptibility in B10.D2 miceC R Gabaglia, B Pedersen, M Hitt, et al.

Human Gene Therapy|August 14, 1999

Use of a liver-specific promoter reduces immune response to the transgene in adenoviral vectorsL Pastore, N Morral, H Zhou, et al.

Journal of Leukocyte Biology|April 1, 1996

Gene transfer for cytokine functional studies in the lung: the multifunctional role of GM-CSF in pulmonary inflammationZ Xing, T Braciak, Y Ohkawara, et al.

The Journal of Clinical Investigation|February 1, 1996

Patient selection may affect gene therapy success. Dominant negative effects observed for ornithine transcarbamylase in mouse and human hepatocytesM A Morsy, J Z Zhao, T T Ngo, et al.

Journal of Thrombosis and Haemostasis : JTH|January 14, 2004

Factors influencing therapeutic efficacy and the host immune response to helper-dependent adenoviral gene therapy in hemophilia A miceB D Brown, C X Shi, F E M Rawle, et al.

Transplantation Proceedings|March 20, 1999

Transplanted hepatocytes infected with a complement receptor type 1 (CR1)-containing recombinant adenovirus are resistant to hyperacute rejectionJ M Hammel, S K Elfeki, N Kobayashi, et al.

Human Gene Therapy|January 5, 1999

High doses of a helper-dependent adenoviral vector yield supraphysiological levels of alpha1-antitrypsin with negligible toxicityN Morral, R J Parks, H Zhou, et al.

Virology|April 1, 1993

Protective immunity to rotavirus-induced diarrhoea is passively transferred to newborn mice from naive dams vaccinated with a single dose of a recombinant adenovirus expressing rotavirus VP7scG W Both, L J Lockett, V Janardhana, et al.

Cancer Gene Therapy|July 31, 2001

Tricistronic viral vectors co-expressing interleukin-12 (1L-12) and CD80 (B7-1) for the immunotherapy of cancer: preclinical studies in myelomaX Y Wen, S Mandelbaum, Z H Li, et al.

Pageof 19

Search research articles

Showing results (151-160 of 186) with videos related to

Sort By:

Pageof 19

The Journal of General Virology|October 1, 1993

Mouse hepatitis virus spike and nucleocapsid proteins expressed by adenovirus vectors protect mice against a lethal infectionJ G Wesseling, G J Godeke, V E Schijns, et al.

Journal of Immunology (Baltimore, Md. : 1950)|January 23, 1999

Human Gene Therapy|August 14, 1999

Use of a liver-specific promoter reduces immune response to the transgene in adenoviral vectorsL Pastore, N Morral, H Zhou, et al.

Journal of Leukocyte Biology|April 1, 1996

Gene transfer for cytokine functional studies in the lung: the multifunctional role of GM-CSF in pulmonary inflammationZ Xing, T Braciak, Y Ohkawara, et al.

The Journal of Clinical Investigation|February 1, 1996

Patient selection may affect gene therapy success. Dominant negative effects observed for ornithine transcarbamylase in mouse and human hepatocytesM A Morsy, J Z Zhao, T T Ngo, et al.

Journal of Thrombosis and Haemostasis : JTH|January 14, 2004

Factors influencing therapeutic efficacy and the host immune response to helper-dependent adenoviral gene therapy in hemophilia A miceB D Brown, C X Shi, F E M Rawle, et al.

Transplantation Proceedings|March 20, 1999

Transplanted hepatocytes infected with a complement receptor type 1 (CR1)-containing recombinant adenovirus are resistant to hyperacute rejectionJ M Hammel, S K Elfeki, N Kobayashi, et al.

Human Gene Therapy|January 5, 1999

High doses of a helper-dependent adenoviral vector yield supraphysiological levels of alpha1-antitrypsin with negligible toxicityN Morral, R J Parks, H Zhou, et al.

Virology|April 1, 1993

Cancer Gene Therapy|July 31, 2001

Tricistronic viral vectors co-expressing interleukin-12 (1L-12) and CD80 (B7-1) for the immunotherapy of cancer: preclinical studies in myelomaX Y Wen, S Mandelbaum, Z H Li, et al.

Pageof 19